Abstract
Validation of a Clinical Scale for Defining RBD Severity in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium (P2-7.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have